As of today (2026-06-27), Camlin Fine Sciences's weighted average cost of capital is 15.69%%. Camlin Fine Sciences's ROIC % is 9.72% (calculated using TTM income statement data).
Camlin Fine Sciences earns returns that do not match up to its cost of capital. It will destroy value as it grows.
For a comprehensive WACC calculation, please access the WACC Calculator.
Camlin Fine Sciences (NSE:CAMLINFINE) WACC % Explanation
Because it costs money to raise capital. A firm that generates higher ROIC % than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.
As of today, Camlin Fine Sciences's weighted average cost of capital is 15.69%%. Camlin Fine Sciences's ROIC % is 9.72% (calculated using TTM income statement data).
Camlin Fine Sciences earns returns that do not match up to its cost of capital. It will destroy value as it grows.
Be Aware
1. GuruFocus uses book value of debt (D) to do the calculation. It is simplified by adding latest one-year quarterly average Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation together.
For companies that report quarterly, GuruFocus combines all of the most recent year's quarterly debt data from the beginning of the year to the year-end and calculates the average.
For companies that report semi-annually, GuruFocus combines all of the most recent year's semi-annual debt data from the start of the year to the year-end and calculates the average.
For companies that report annually, GuruFocus combines the beginning and ending annual debt data from the most recent year and then calculates the average.
2. The WACC formula discussed above does not include Preferred Stock. Please adjust if preferred stock is considered.
3. (Expected Return of the Market - Risk-Free Rate of Return) is also called market premium. GuruFocus requires market premium to be 6%.
4. GuruFocus uses the latest TTM Interest Expense divided by the latest one-year quarterly average debt to get the simplified cost of debt.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:CAMLINFINE vs LIN, SHW, ECL: WACC % Comparison
For the Specialty Chemicals subindustry, Camlin Fine Sciences's WACC %, along with its competitors' market caps and WACC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Camlin Fine Sciences WACC % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Camlin Fine Sciences's WACC % distribution charts can be found below:
* The bar in red indicates where Camlin Fine Sciences's WACC % falls into.
The weighted average cost of capital (WACC) is the rate that a company is expected to pay on average to all its security holders to finance its assets. The WACC is commonly referred to as the firm's cost of capital. Generally speaking, a company's assets are financed by debt and equity. WACC is the average of the costs of these sources of financing, each of which is weighted by its respective use in the given situation. By taking a weighted average, we can see how much interest the company has to pay for every dollar it finances.
WACC
=
E
/
(E + D)
*
Cost of Equity
+
D
/
(E + D)
*
Cost of Debt
*
(1 - Tax Rate)
1. Weights:
Generally speaking, a company's assets are financed by debt and equity. We need to calculate the weight of equity and the weight of debt.
The market value of equity (E) is also called "Market Cap". As of today, Camlin Fine Sciences's market capitalization (E) is ₹26191.691 Mil.
The market value of debt is typically difficult to calculate, therefore, GuruFocus uses book value of debt (D) to do the calculation. It is simplified by adding the latest one-year quarterly average Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation together. As of Mar. 2026, Camlin Fine Sciences's latest one-year quarterly average Book Value of Debt (D) is ₹6910.3513 Mil.
a) weight of equity = E / (E + D) = 26191.691 / (26191.691 + 6910.3513) = 0.7912
b) weight of debt = D / (E + D) = 6910.3513 / (26191.691 + 6910.3513) = 0.2088
2. Cost of Equity:
GuruFocus uses Capital Asset Pricing Model (CAPM) to calculate the required rate of return. The formula is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)
a) GuruFocus uses 10-Year Treasury Constant Maturity Rate as the risk-free rate. It is updated daily. The current risk-free rate is 7.02%. Please go to Economic Indicators page for more information. Please note that we use the 10-Year Treasury Constant Maturity Rate of the country/region where the company is headquartered. If the data for that country/region is not available, then we will use the 10-Year Treasury Constant Maturity Rate of the United States as default.
b) Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. Camlin Fine Sciences's beta is 1.6549.
c) (Expected Return of the Market - Risk-Free Rate of Return) is also called market premium. GuruFocus requires market premium to be 6%.
Cost of Equity = 7.02% + 1.6549 * 6% = 16.9494%
3. Cost of Debt:
GuruFocus uses latest TTM Interest Expense divided by the latest one-year quarterly average debt to get the simplified cost of debt.
As of Mar. 2026, Camlin Fine Sciences's interest expense (positive number) was ₹761.671 Mil. Its total Book Value of Debt (D) is ₹6910.3513 Mil.
Cost of Debt = 761.671 / 6910.3513 = 11.0222%.
4. Multiply by one minus TTM Tax Rate:
GuruFocus uses the most recent TTM Tax Expense divided by the most recent TTM Pre-Tax Income to calculate the tax rate. The calculated TTM tax rate is limited to between 0% and 100%. If the calculated tax rate is higher than 100%, it is set to 100%. If the calculated tax rate is less than 0%, it is set to 0%.
The latest calculated TTM Tax Rate = -2.893 / -374.734 = 0.77%.
Camlin Fine Sciences's Weighted Average Cost Of Capital (WACC) for Today is calculated as:
WACC
=
E / (E + D)
*
Cost of Equity
+
D / (E + D)
*
Cost of Debt
*
(1 - Tax Rate)
=
0.7912
*
16.9494%
+
0.2088
*
11.0222%
*
(1 - 0.77%)
=
15.69%
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Camlin Fine Sciences (NSE:CAMLINFINE) has a WACC % of 15.69% as of Jun. 27, 2026. The weighted average cost of capital (WACC) is the average rate a company pays to finance assets. View historical data on Camlin Fine Sciences and its competitors. This is 18% above median its historical median of 13.29. Over the past decade, Camlin Fine Sciences' WACC % has ranged from 9.63 to 15.77. According to the industry distribution chart, Camlin Fine Sciences ranks #1532 out of 1637 companies in the Chemicals industry, placing it in the top 93.6%.
Is Camlin Fine Sciences' WACC % too high?
Camlin Fine Sciences' current WACC % of 15.69% is 18% above median its 10-year median of 13.29. Over the past 10 years, this metric has ranged from a low of 9.63 to a high of 15.77. The Chemicals industry median WACC % is 9.20. Camlin Fine Sciences' value of 15.69% is 70.5% above this industry median. Based on the distribution chart, Camlin Fine Sciences ranks #1532 out of 1637 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Camlin Fine Sciences has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Camlin Fine Sciences' WACC % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Camlin Fine Sciences ranks #1532 out of 1637 companies for WACC %. This places Camlin Fine Sciences in the lower half of its industry. The industry median WACC % is 9.20. Camlin Fine Sciences' value of 15.69% is 70.5% above this benchmark. Historically, Camlin Fine Sciences' own WACC % has ranged from 9.63 to 15.77 over the past decade. While the company's 10-year median is 13.29 vs. the industry median of 9.20, Camlin Fine Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good WACC % for a Chemicals company?
The median WACC % among Chemicals companies is 9.20, based on 1,637 companies in the industry. Companies in the top quartile (top 25%) have a WACC % significantly above this median, while those in the bottom quartile fall well below. However, WACC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Camlin Fine Sciences's current WACC % of 15.69% is 70.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high WACC % mean?
A high WACC % can signal that a stock is expensive relative to its fundamentals. The weighted average cost of capital (WACC) is the average rate a company pays to finance assets. View historical data on Camlin Fine Sciences and its competitors. For the Chemicals industry, the median WACC % is 9.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Camlin Fine Sciences's current WACC % is 15.69%, which is 18% above median its own 10-year median of 13.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Camlin Fine Sciences stock overvalued right now?
Based on GuruFocus' analysis, Camlin Fine Sciences (NSE:CAMLINFINE) is currently considered Fairly Valued. The stock's GF Value™ is ₹142.22, compared to a current price of ₹136.37 — trading 4.1% below its estimated fair value. The current WACC % is 15.69%, which is 18% above median its 10-year median of 13.29 and 70.5% above the Chemicals industry median of 9.20. Camlin Fine Sciences' overall GF Score™ is 58/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is WACC % calculated?
WACC % is calculated from a company's financial statements. For Camlin Fine Sciences (NSE:CAMLINFINE), the current WACC % is 15.69% as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Camlin Fine Sciences (NSE:CAMLINFINE) Overvalued in 2026?
Based on GuruFocus' analysis, Camlin Fine Sciences stock appears to be undervalued.
The current stock price of ₹136.37 is trading 4.1% below its estimated GF Value™ of ₹142.22.
GuruFocus considers Camlin Fine Sciences to be Fairly Valued.
Key valuation signals for NSE:CAMLINFINE:
WACC %: 15.69% (18% above median its 10-year median of 13.29)
GF Value™: ₹142.22 vs. price of ₹136.37 (4.1% below fair value)
Industry Position: 70.5% above the Chemicals median (#1532 of 1637)
No single metric tells the full story. See the NSE:CAMLINFINE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Camlin Fine Sciences Ltd is engaged in research, development, manufacturing, commercializing, and marketing of specialty chemicals and blends. These chemicals are used in food, feed, animal and pet nutrition and industrial products. The Company has only one reportable segment, namely, Speciality Chemicals. The company's product portfolio consists of Shelf life solutions, Aroma ingredients, Performance chemicals and Health & Wellness. Shelf life extension solutions include antioxidant solutions which are used to increase the shelf life of oils and. Aroma vertical includes a production of Vanillin and Ethyl Vanillin. Performance Chemicals consist of Guaiacol, Veratrole, TBC, and MEHQ and are used in sectors such as food flavoring, pharmaceuticals intermediate fragrance industry.
58GF Score
Get the complete analysis for NSE:CAMLINFINE
WACC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CAMLINFINE has been successfully added to your 
